Raloxifene Hydrochloride Tablet
Product Images NDC 69097-825

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 69097-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Raloxifene Hydrochloride Tablets 60 mg

Raloxifene Hydrochloride Tablets 60 mg
This is a medication called Raloxifene Hydrochloride, prescribed for medical use only, with each tablet containing 0% of active ingredients. It is manufactured by Cipla USA Inc. and comes in a pack of 30 tablets. The tablets are coated and contain caffeine. The instructions indicate that the medication should be stored in a tight container. The text includes some manufacturing details, such as a lot number and product number.*
FDA Label Image

Raloxifene Hydrochloride Str

FDA Label Image

Raloxifene Graph

Raloxifene Graph
This is a statistical report on the percentage change in total hip bone mineral density from baseline in 24-month studies of placebo, raloxifene, and CE subjects. The report includes data from studies in both North America and Europe, as well as a specific study involving hysterectomized women taking GE with conjugated estrogens. The data was analyzed using a fast observation carried forward technique. The report includes a figure (Figure 1) displaying the results of the analysis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.